BillionToOne
Develops molecular diagnostics for prenatal screening and cancer treatment selection.
$93.00
After-hours close−0.31 (−0.33%)
At close$93.31(−1.94%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Oct 2026 | $0.15 | — | — |
| Aug 2026 | $0.18 | $0.15 | −18.2% |
| May 2026 | $0.03 | $0.34 | +981.8% |
| Mar 2026 | $0.06 | $0.11 | +82.7% |
| Dec 2025 | $0.14 | $0.10 | −28.3% |
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Oct 6, 2026 | $0.15 | — | — | $116.3M | — | — |
| Aug 5, 2026 | $0.18 | $0.15 | −18.2% | $109.2M | $109.4M | +0.2% |
| May 6, 2026 | $0.03 | $0.34 | +981.8% | $97.1M | $108.4M | +11.6% |
| Mar 4, 2026 | $0.06 | $0.11 | +82.7% | $87.2M | $96.1M | +10.2% |
| Dec 9, 2025 | $0.14 | $0.10 | −28.3% | $82.9M | $83.5M | +0.8% |